Skip to main content
Premium Trial:

Request an Annual Quote

OpGen Partners With Stratos and Micronics to Commercialize Optical Mapping System

NEW YORK, April 5 (GenomeWeb News) - OpGen Technologies has partnered with Stratos Product Development and Micronics to develop and commercialize its first product, called the Optical Mapping System, the trio said today.


OpGen's Optical Mapping detects genome rearrangements, including insertions/deletions, translocations, inversions, repeats and gene amplification, the companies said. OpGen has partnered with the two Pacific Northwest life science firms to develop the commercial version of its system that can be used in-house. OpGen currently offers access to its technology as a service.


Under the terms of the agreement, Stratos will bring to the table its know-how in technology commercialization, systems integration, instrumentation development, and regulatory compliance, while Micronics will develop the disposable device on which the fluidics assay of the Optical Mapping technology is performed.


OpGen said in a statement earlier this week that it is aiming to launch the system in 2007.


Financial details were not disclosed.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.